|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of products sold | |||||
| Gross profit | |||||
| Selling, general and administrative expense | |||||
| Advertising and sales promotion expense | |||||
| Research and development expense | |||||
| Restructuring charges | |||||
| Goodwill, Impairment Loss | |||||
| Operating income | |||||
| Cost of early retirement of long-term debt | |||||
| Interest expense associated with debt | |||||
| Other (income) expense, net | |||||
| Earnings before income taxes | |||||
| Income tax (benefit) provision | |||||
| Net earnings | |||||
| Other comprehensive income (loss), net of tax: | |||||
| Foreign currency translation adjustments | |||||
| Pension and postretirement activity, net of tax | |||||
| Deferred gain (loss) on hedging activity, net of tax | |||||
| Total other comprehensive income (loss), net of tax | |||||
| Total comprehensive income | |||||
| Basic weighted-average shares outstanding (in shares) | |||||
| Diluted weighted-average shares outstanding (in shares) | |||||
| Basic | |||||
| Diluted | |||||
Loading...